Prognostic effect of Ki-67 in common clinical subgroups of patients with HER2-negative, hormone receptor-positive early breast cancer-Reference-Cited by-同舟云学术

Prognostic effect of Ki-67 in common clinical subgroups of patients with HER2-negative, hormone receptor-positive early breast cancer

Published:2019-03-13 Issue:3 Volume:175 Page:617-625
ISSN:0167-6806
Container-title:Breast Cancer Research and Treatment
language:en
Short-container-title:Breast Cancer Res Treat

Author:

Fasching Peter A.^ORCID,Gass Paul,Häberle Lothar,Volz Bernhard,Hein Alexander,Hack Carolin C.,Lux Michael P.,Jud Sebastian M.,Hartmann Arndt,Beckmann Matthias W.,Slamon Dennis J.,Erber Ramona

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s10549-019-05198-9.pdf

Reference50 articles.

1. Allegra CJ, Paik S, Colangelo LH, Parr AL, Kirsch I, Kim G, Klein P, Johnston PG, Wolmark N, Wieand HS (2003) Prognostic value of thymidylate synthase, Ki-67, and p53 in patients with Dukes’ B and C colon cancer: a National Cancer Institute-National Surgical Adjuvant Breast and Bowel Project collaborative study. J Clin Oncol 21:241–250. https://doi.org/10.1200/JCO.2003.05.044

2. Andre F, Arnedos M, Goubar A, Ghouadni A, Delaloge S (2015) Ki67—no evidence for its use in node-positive breast cancer. Nat Rev Clin Oncol 12:296–301. https://doi.org/10.1038/nrclinonc.2015.46

3. Beckmann MW, Brucker C, Hanf V, Rauh C, Bani MR, Knob S, Petsch S, Schick S, Fasching PA, Hartmann A, Lux MP, Haberle L (2011) Quality assured health care in certified breast centers and improvement of the prognosis of breast cancer patients. Onkologie 34:362–367. https://doi.org/10.1159/000329601

4. Boros M, Moncea D, Moldovan C, Podoleanu C, Georgescu R, Stolnicu S (2017) Intratumoral heterogeneity for Ki-67 index in invasive breast carcinoma: a study on 131 consecutive cases. Appl Immunohistochem Mol Morphol 25:338–340. https://doi.org/10.1097/PAI.0000000000000315

5. Caldarella A, Crocetti E, Paci E (2014) Ki67 in breast cancer: a useful prognostic marker? Ann Oncol 25:542. https://doi.org/10.1093/annonc/mdt561

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A retrospective analysis of clinicopathological characteristics and risk factors for recurrence in young patients with breast cancer;Gland Surgery;2024-07

2. Long-term Follow-up and Safety of Patients after an Upfront Therapy with Letrozole for Early Breast Cancer in Routine Clinical Care – The PreFace Study;Senologie - Zeitschrift für Mammadiagnostik und -therapie;2024-05-23

3. Integrating clinical data and ultrasonographic imaging for non-invasive prediction of HER2 status in breast cancer;2024-03-14

4. Tumor-associated neutrophils are a negative prognostic factor in luminal breast cancers lacking immunosuppressive macrophage recruitment;2024-03-07

5. Identification of Patients with Early HR+ HER2− Breast Cancer at High Risk of Recurrence;Geburtshilfe und Frauenheilkunde;2024-02